Keenova Therapeutics plc Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 848.60M USD | Gross Profit |
| Revenue | (m) | |
| Cost of products and services | 1.10B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $848.60M | (m) | $1.10B | (m) |
| 2026-03-31 | $717.30M | (m) | $974.40M | (m) |
| 2025-12-31 | $642.80M | (m) | $787.80M | (m) |
| 2025-09-26 | (m) | (m) | (m) | (m) |
| 2025-06-27 | $443.10M | (m) | $129.70M | (m) |
| 2025-03-28 | $487.40M | (m) | $335.40M | (m) |
| 2024-12-27 | $539.30M | (m) | $544.10M | (m) |
| 2024-09-27 | (m) | (m) | (m) | (m) |
| 2024-06-28 | (m) | (m) | (m) | (m) |
| 2024-03-29 | (m) | (m) | (m) | (m) |
| 2023-12-29 | (m) | (m) | (m) | (m) |
| 2023-11-14 | (m) | (m) | (m) | (m) |
| 2023-09-29 | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) |
| 2022-12-30 | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) |
| 2022-07-01 | (m) | (m) | (m) | (m) |
| 2022-06-16 | (m) | (m) | (m) | (m) |
| 2022-04-01 | (m) | (m) | (m) | (m) |
| 2021-12-31 | $891.70M | (m) | $1.32B | (m) |
| 2021-09-24 | $963.70M | (m) | (m) | (m) |
| 2021-06-25 | $1.07B | (m) | (m) | (m) |
| 2021-03-26 | $636.00M | (m) | (m) | (m) |
| 2020-12-25 | (m) | (m) | (m) | (m) |
| 2020-09-25 | $732.00M | (m) | (m) | (m) |
| 2020-06-26 | $761.00M | (m) | (m) | (m) |
| 2020-03-27 | $1.37B | (m) | (m) | (m) |
| 2019-12-27 | $1.42B | (m) | (m) | (m) |
| 2019-09-27 | (m) | (m) | (m) | (m) |
| 2019-06-28 | (m) | (m) | (m) | (m) |
| 2019-03-29 | $1.46B | (m) | $1.79B | (m) |
| 2018-12-28 | $1.47B | (m) | (m) | (m) |
| 2018-09-28 | (m) | (m) | (m) | (m) |
| 2018-06-29 | (m) | (m) | (m) | (m) |
| 2018-03-30 | $1.59B | (m) | (m) | (m) |
| 2017-12-29 | $1.66B | (m) | (m) | (m) |
| 2017-09-29 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | $1.85B | (m) | (m) | (m) |
| 2016-12-30 | $1.85B | (m) | $1.55B | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-24 | (m) | (m) | (m) | (m) |
| 2016-03-25 | (m) | (m) | (m) | (m) |
| 2015-12-25 | $1.72B | (m) | (m) | (m) |
| 2015-09-25 | $1.62B | (m) | (m) | (m) |
| 2015-06-26 | (m) | (m) | (m) | (m) |
| 2015-03-27 | (m) | (m) | (m) | (m) |
| 2014-12-26 | $1.02B | (m) | (m) | (m) |
| 2014-09-26 | $1.06B | (m) | (m) | (m) |
| 2014-06-27 | (m) | (m) | (m) | (m) |
| 2014-03-28 | (m) | (m) | (m) | (m) |
| 2013-12-27 | $805.00M | (m) | (m) | (m) |
| 2013-09-27 | $1.02B | (m) | (m) | (m) |
| 2013-06-28 | (m) | (m) | (m) | (m) |
| 2013-03-29 | (m) | (m) | (m) | (m) |
| 2012-12-28 | $963.50M | (m) | (m) | (m) |
| 2012-09-28 | $964.80M | (m) | (m) | (m) |
| 2012-06-29 | (m) | (m) | (m) | (m) |
| 2012-03-30 | (m) | (m) | (m) | (m) |
| 2011-12-30 | (m) | (m) | (m) | (m) |
| 2011-09-30 | $914.90M | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.